Technically, the stock has been trading like PSTI did a few weeks ago. I'm expecting the stock to hold the $4.90 level until 12:30 and then do a dumperooni.
I've been in this stock for several years so my cost basis is low. It trades in ranges. Even if company does get FDA approval, it still has years to go before products get to market in any full rollout. Correct me if I'm but I thought the company said 5-7 years is when they expect the majority of the revenue to start.
The best immediate hope for shareholders is if some big pharma buys them out.
I've got a bunch of shares from when no one cared about this stock. I know when it's time to take at least some off the table and I have between $4.90 and $5.10 and I won't loose any sleep over it.
Of course i hope the stock goes to the moon but nothing goes straight up, especially this stock...even with a conference in a couple of weeks.
Market Data 
Markets 
AI
